183 related articles for article (PubMed ID: 21898661)
21. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
22. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
Rebbeck TR; Mitra N; Domchek SM; Wan F; Chuai S; Friebel TM; Panossian S; Spurdle A; Chenevix-Trench G; ; Singer CF; Pfeiler G; Neuhausen SL; Lynch HT; Garber JE; Weitzel JN; Isaacs C; Couch F; Narod SA; Rubinstein WS; Tomlinson GE; Ganz PA; Olopade OI; Tung N; Blum JL; Greenberg R; Nathanson KL; Daly MB
Cancer Res; 2009 Jul; 69(14):5801-10. PubMed ID: 19584272
[TBL] [Abstract][Full Text] [Related]
23. RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
Fan C; Zhang J; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Int J Cancer; 2018 Oct; 143(8):1935-1942. PubMed ID: 29726012
[TBL] [Abstract][Full Text] [Related]
24. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.
Figueiredo JC; Haile RW; Bernstein L; Malone KE; Largent J; Langholz B; Lynch CF; Bertelsen L; Capanu M; Concannon P; Borg A; Børresen-Dale AL; Diep A; Teraoka S; Torngren T; Xue S; Bernstein JL
Breast Cancer Res Treat; 2010 Feb; 120(1):175-83. PubMed ID: 19597986
[TBL] [Abstract][Full Text] [Related]
25. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.
Stovall M; Smith SA; Langholz BM; Boice JD; Shore RE; Andersson M; Buchholz TA; Capanu M; Bernstein L; Lynch CF; Malone KE; Anton-Culver H; Haile RW; Rosenstein BS; Reiner AS; Thomas DC; Bernstein JL;
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1021-30. PubMed ID: 18556141
[TBL] [Abstract][Full Text] [Related]
26. Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study.
Lee S; Liang X; Woods M; Reiner AS; Concannon P; Bernstein L; Lynch CF; Boice JD; Deasy JO; Bernstein JL; Oh JH
PLoS One; 2020; 15(2):e0226157. PubMed ID: 32106268
[TBL] [Abstract][Full Text] [Related]
27. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
[TBL] [Abstract][Full Text] [Related]
28. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
Han W; Kim KY; Yang SJ; Noh DY; Kang D; Kwack K
Cancer; 2012 Feb; 118(3):594-602. PubMed ID: 21751184
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
[TBL] [Abstract][Full Text] [Related]
30. Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USA.
Hill DA; Preston-Martin S; Ross RK; Bernstein L
Cancer Causes Control; 2002 Oct; 13(8):711-8. PubMed ID: 12420949
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
Reding KW; Bernstein JL; Langholz BM; Bernstein L; Haile RW; Begg CB; Lynch CF; Concannon P; Borg A; Teraoka SN; Törngren T; Diep A; Xue S; Bertelsen L; Liang X; Reiner AS; Capanu M; Malone KE;
Breast Cancer Res Treat; 2010 Sep; 123(2):491-8. PubMed ID: 20135344
[TBL] [Abstract][Full Text] [Related]
32. ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations.
McDuff SGR; Bellon JR; Shannon KM; Gadd MA; Dunn S; Rosenstein BS; Ho AY
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1373-1382. PubMed ID: 33545302
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.
Einarsdóttir K; Rosenberg LU; Humphreys K; Bonnard C; Palmgren J; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
Breast Cancer Res; 2006; 8(6):R67. PubMed ID: 17132159
[TBL] [Abstract][Full Text] [Related]
34. DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus.
Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Hadjisavvas A; Kyriacou K
Breast Cancer Res Treat; 2009 Jun; 115(3):623-7. PubMed ID: 18553220
[TBL] [Abstract][Full Text] [Related]
35. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
36. Germline Variants in DNA Repair Genes, Diagnostic Radiation, and Risk of Thyroid Cancer.
Sandler JE; Huang H; Zhao N; Wu W; Liu F; Ma S; Udelsman R; Zhang Y
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):285-294. PubMed ID: 29263185
[No Abstract] [Full Text] [Related]
37. The MRN protein complex genes: MRE11 and RAD50 and susceptibility to head and neck cancers.
Ziółkowska-Suchanek I; Mosor M; Wierzbicka M; Rydzanicz M; Baranowska M; Nowak J
Mol Cancer; 2013 Sep; 12(1):113. PubMed ID: 24079363
[TBL] [Abstract][Full Text] [Related]
38. Variants in DNA double-strand break repair genes and breast cancer susceptibility.
Kuschel B; Auranen A; McBride S; Novik KL; Antoniou A; Lipscombe JM; Day NE; Easton DF; Ponder BA; Pharoah PD; Dunning A
Hum Mol Genet; 2002 Jun; 11(12):1399-407. PubMed ID: 12023982
[TBL] [Abstract][Full Text] [Related]
39. Multi-center screening of mutations in the ATM gene among women with breast cancer - the WECARE Study.
Berstein JL; Concannon P; Langholz B; Thompson WD; Bernstein L; Stovall M; Thomas DC;
Radiat Res; 2005 Jun; 163(6):698-9. PubMed ID: 16044499
[No Abstract] [Full Text] [Related]
40. Carcinogen-induced DNA double strand break repair in sporadic breast cancer.
Zhang C; Naftalis E; Euhus D
J Surg Res; 2006 Sep; 135(1):120-8. PubMed ID: 16650867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]